Search company, investor...

Founded Year

2002

Stage

Corporate Majority | Acquired

Total Raised

$3.2M

About Molecular Vision

Molecular Vision is an Imperial College spin-out company that develops low-cost diagnostic devices for use in the doctor's surgery and in the home. Its devices combine microfluidic chips with organic-semiconductor light-sources and photodetectors to provide lab-quality diagnostic tests in a miniaturised, disposable format.

Headquarters Location

BioIncIncubator Unit Bessemer Building (RSM) Level 1, Prince Consort Road

SW7 2BP,

United Kingdom

Loading...

Loading...

Expert Collections containing Molecular Vision

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Molecular Vision is included in 1 Expert Collection, including Semiconductors, Chips, and Advanced Electronics.

S

Semiconductors, Chips, and Advanced Electronics

6,648 items

Companies in the semiconductors & HPC space, including integrated device manufacturers (IDMs), fabless firms, semiconductor production equipment manufacturers, electronic design automation (EDA), advanced semiconductor material companies, and more

Molecular Vision Patents

Molecular Vision has filed 11 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

5/24/2017

12/22/2020

Analytical chemistry, Optical devices, Spectroscopy, Chromatography, Sensors

Grant

Application Date

5/24/2017

Grant Date

12/22/2020

Title

Related Topics

Analytical chemistry, Optical devices, Spectroscopy, Chromatography, Sensors

Status

Grant

Molecular Vision Frequently Asked Questions (FAQ)

  • When was Molecular Vision founded?

    Molecular Vision was founded in 2002.

  • What is Molecular Vision's latest funding round?

    Molecular Vision's latest funding round is Corporate Majority.

  • How much did Molecular Vision raise?

    Molecular Vision raised a total of $3.2M.

  • Who are the investors of Molecular Vision?

    Investors of Molecular Vision include Abingdon Health, Acron Genomics and Touchstone Innovations.

Loading...

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.